GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 3:20 p.m. ET on Sept. 4, 2024.

Live and replay webcasts may be accessed in the investor relations section of GRAIL’s website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL’s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302227805.html

SOURCE GRAIL, Inc.

Staff

Recent Posts

KFSHRC Sets New Global Standards in Digital Healthcare Education

RIYADH, Saudi Arabia, Aug. 24, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…

9 hours ago

Capital and Business Alliance Formed Between MEDIROM MOTHER Labs and NFES Technologies

NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen…

9 hours ago

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a…

9 hours ago

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”)…

9 hours ago

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero…

9 hours ago

Artificial Intelligence-as-a-Service (AIaaS) Market to Grow by USD 79.8 Billion (2024-2028) Driven by R and D Investments, AI’s Market Impact- Technavio Report

NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global artificial intelligence-as-a-service (AIaaS) market  size is…

18 hours ago